Reducing Breathlessness With Dronabinol in COPD Patients

NCT06473701 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

COPD
Breathlessness
Cannabis

Interventions

DRUG: Dronabinol 2.5mg Capsule
DRUG: Placebo

Sponsor

Vejle Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]